Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Which stocks will surge next?
Unlock AI-picked Stocks
EXACT Sciences Corporation (EXAS)
Add to/Remove from a Portfolio
Add to Watchlist
58.85
-4.39
-6.93%
Type:
Equity
Market:
United States
- Volume: 1,478,145
- Bid/Ask: 0.00 / 0.00
- Day's Range: 58.40 - 62.47
EXACT Sciences
58.85
-4.39
-6.93%
- Discussions
- Recent Sentiments
- User Rankings
EXAS User Rankings
Bellow, users are ranked according to the performance of their sentiments for the EXACT Sciences Corporation stock.
| Rank | Username | Total | Closed | Winning | Win % | Chg. % |
|---|---|---|---|---|---|---|
| 1 | Koen De Smet | 1 | 1 | 1 | 100 | +58.17% |
| 2 | Allan Burnett | 1 | 1 | 1 | 100 | +56.9% |
| 3 | John Larch | 8 | 8 | 4 | 50 | +43.17% |
| 4 | Rambabu Verma | 1 | 1 | 1 | 100 | +26.52% |
| 5 | Xavier Tang | 1 | 1 | 1 | 100 | +24.5% |
| 6 | Яна Заболошина | 1 | 1 | 1 | 100 | +21.74% |
| 7 | Michael Torrez | 1 | 1 | 1 | 100 | +21.52% |
| 8 | Tibi Oprea | 1 | 1 | 1 | 100 | +21.29% |
| 9 | davide garulli | 4 | 4 | 3 | 75 | +19.36% |
| 10 | Simone Marticke | 1 | 1 | 1 | 100 | +14.41% |
| 11 | Maurice Seibeld | 1 | 1 | 1 | 100 | +14.17% |
| 12 | Mateo Romero | 1 | 0 | 0 | 0 | +13.83% |
| 13 | Zoanne Pitts | 1 | 1 | 1 | 100 | +13.73% |
| 14 | Michael Norton | 1 | 1 | 1 | 100 | +13.39% |
| 15 | Thierry Jacobsoone | 1 | 1 | 1 | 100 | +12.92% |
| 16 | Giacomo Rosina | 1 | 1 | 1 | 100 | +12.76% |
| 17 | Yakup Şensoy | 1 | 1 | 1 | 100 | +12.65% |
| 18 | עומרי פרץ | 1 | 1 | 1 | 100 | +12.64% |
| 19 | Gerard Meyer | 1 | 1 | 1 | 100 | +12.2% |
| 20 | Amit Doshi | 1 | 1 | 1 | 100 | +12.18% |
| 21 | Mistral Magic | 1 | 1 | 1 | 100 | +11.24% |
| 22 | Ron Beech | 2 | 2 | 2 | 100 | +9.08% |
| 23 | Nuno Lemos | 1 | 1 | 1 | 100 | +8.56% |
| 24 | Flangea Marius | 1 | 1 | 1 | 100 | +8.52% |
| 25 | Alexander Aleksandrov | 1 | 0 | 0 | 0 | +5.3% |
| 26 | Todd DeVries | 1 | 0 | 0 | 0 | +5.23% |
| 27 | Angus Wink | 1 | 0 | 0 | 0 | +5.04% |
| 28 | Haig Stewart | 1 | 1 | 1 | 100 | +4.95% |
| 29 | 白藤 勇太 | 1 | 0 | 0 | 0 | +3.69% |
| 30 | Михаил Овчинников | 2 | 2 | 1 | 50 | +3.1% |
| 31 | FABRICE RightBYOU | 1 | 1 | 1 | 100 | +2.84% |
| 32 | Nate Qaz | 1 | 1 | 1 | 100 | +2.74% |
| 33 | juan pedro Jimenez | 1 | 1 | 1 | 100 | +2.35% |
| 34 | Emanuele Marini | 1 | 1 | 1 | 100 | +2.34% |
| 35 | Rogue Trader | 1 | 1 | 1 | 100 | +2.13% |
| 36 | Todd Collins | 3 | 3 | 1 | 33.33 | +1.84% |
| 37 | Joseph Liba | 1 | 1 | 1 | 100 | +1.57% |
| 38 | Leandro Pacini | 1 | 1 | 1 | 100 | +1.32% |
| 39 | Pat McQueeney | 1 | 1 | 1 | 100 | +0.89% |
| 40 | Grant Strudwick | 1 | 1 | 1 | 100 | +0.13% |
| 41 | Byron Petrone | 1 | 1 | 0 | 0 | 0% |
| 42 | Deacon Ross | 1 | 1 | 0 | 0 | -0.26% |
| 43 | Arseni Who | 1 | 1 | 0 | 0 | -0.56% |
| 44 | Olegkuat Esquaire | 1 | 1 | 0 | 0 | -0.89% |
| 45 | javier murcia | 1 | 1 | 0 | 0 | -1.53% |
| 46 | Yinlee Chin | 1 | 1 | 0 | 0 | -1.7% |
| 47 | Ryan Smith | 1 | 1 | 0 | 0 | -2.65% |
| 48 | Antonio Fernández | 1 | 1 | 0 | 0 | -3.38% |
| 49 | Nacho Hernandez | 2 | 2 | 1 | 50 | -3.85% |
| 50 | עמוס קוק | 1 | 1 | 0 | 0 | -4.65% |
Write your thoughts about EXACT Sciences Corporation
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review